Shao, Liang
Luo, Xu
Ye, Yingchao
Liu, Le
Cai, Yaoyao
Xia, Yun
Papadimos, Thomas J.
Wang, Quanguang
Pan, Linmin
Article History
Received: 12 September 2022
Accepted: 21 November 2022
First Online: 29 November 2022
Declarations
:
: This prospective, double-blind, randomized controlled study adhered to the World Medical Association Declaration of Helsinki. Data are presented in accordance with the Consolidated Standards of Reporting Trials (CONSORT) statement. The trial was approved by the institutional review board of the First Affiliated Hospital of Wenzhou Medical University (Chairperson Professor Rong Jin), Ouhai District, Wenzhou, Zhejiang, China, on 13/03/2017. The study was registered in the Chinese Clinical Trial Registration Center onExternalRef removed(registration number: ChiCTR-IOR-17010853). Written informed consent was obtained from all volunteers before the study procedures.
: Not applicable.
: The authors declare no conflicts of interest.